Davis Jeffrey A. 4

What Happened
Jeffrey A. Davis, a director of Labcorp Holdings Inc. (LH), received a grant of 773 restricted stock units (RSUs) on February 10, 2026. The grant is recorded on the Form 4 as 773 derivative securities acquired at $0.00 (i.e., an award rather than a cash purchase). The RSUs represent the contingent right to receive one share of Labcorp common stock per unit upon vesting.

Key Details

• Transaction date: February 10, 2026; Form 4 filed February 12, 2026 (appears timely).
• Transaction type/code: Award/Grant (A); price reported $0.00 per unit.
• Units granted/held: 773 RSUs (the filing reflects the aggregate number of RSUs held by the reporting person).
• Vesting: RSUs vest fully on February 10, 2027 (footnote).
• Derivative note: Each RSU converts to one share when vested—this is not an immediate transfer of common stock.
• Exhibit: Exhibit 24 (Power of Attorney) was included with the filing.

Context
RSU grants are a common form of compensation for executives and directors and do not involve an out-of-pocket purchase. Because these units vest in a year, they do not immediately change the director’s common-stock ownership and should be viewed as a compensation award rather than a direct market signal.